Advertisement
GRFS vs GTX
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GRFS is a Hold and GTX is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
GRFS’s FA Score shows that 1 FA rating(s) are green whileGTX’s FA Score has 2 green FA rating(s).
- GRFS’s FA Score: 1 green, 4 red.
- GTX’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
GRFS’s TA Score shows that 2 TA indicator(s) are bullish while GTX’s TA Score has 4 bullish TA indicator(s).
- GRFS’s TA Score: 2 bullish, 5 bearish.
- GTX’s TA Score: 4 bullish, 5 bearish.
Price Growth
GRFS (@Pharmaceuticals: Major) experienced а -2.79% price change this week, while GTX (@Auto Parts: OEM) price change was -0.29% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.71%. For the same industry, the average monthly price growth was +5.49%, and the average quarterly price growth was +8.52%.
The average weekly price growth across all stocks in the @Auto Parts: OEM industry was -2.40%. For the same industry, the average monthly price growth was +2.65%, and the average quarterly price growth was +9.72%.
Reported Earning Dates
GRFS is expected to report earnings on Jul 24, 2025.
GTX is expected to report earnings on Jul 24, 2025.
Industries' Descriptions
@Pharmaceuticals: Major (-1.71% weekly)The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.
@Auto Parts: OEM (-2.40% weekly)OEM or Original Equipment Manufacturer of auto parts refers to the original producer of a vehicles components, and so OEM car parts are usually identical to the parts used in producing the vehicle in the first place. OEM parts tend to fit the specifications of a particular model, and their compatibility is often guaranteed by the automaker itself. OEM parts could be more expensive to buy (compared to other vendors’ products) when a consumer goes for replacement. However, increased competition from aftermarket parts/third-party vendors could, in some cases, keep EOM prices in check. The industry might progress further in adopting newer technologies like 3D printing to boost supply chain performance and quality. Aptiv PLC, Magna International Inc. and BorgWarner Inc. are major OEMs for autos.
| GRFS | GTX | GRFS / GTX | |
| Capitalization | 5.48B | 2.37B | 231% |
| EBITDA | 640M | 600M | 107% |
| Gain YTD | 16.935 | 14.219 | 119% |
| P/E Ratio | 68.68 | 10.19 | 674% |
| Revenue | 6.54B | 3.89B | 168% |
| Total Cash | 544M | 259M | 210% |
| Total Debt | 11.1B | 1.69B | 656% |
GRFS | GTX | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 17 | 55 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 6 Undervalued | 29 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 41 | |
SMR RATING 1..100 | 87 | 100 | |
PRICE GROWTH RATING 1..100 | 43 | 53 | |
P/E GROWTH RATING 1..100 | 96 | 9 | |
SEASONALITY SCORE 1..100 | 45 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
GRFS's Valuation (6) in the Pharmaceuticals Major industry is in the same range as GTX (29) in the null industry. This means that GRFS’s stock grew similarly to GTX’s over the last 12 months.
GTX's Profit vs Risk Rating (41) in the null industry is somewhat better than the same rating for GRFS (100) in the Pharmaceuticals Major industry. This means that GTX’s stock grew somewhat faster than GRFS’s over the last 12 months.
GRFS's SMR Rating (87) in the Pharmaceuticals Major industry is in the same range as GTX (100) in the null industry. This means that GRFS’s stock grew similarly to GTX’s over the last 12 months.
GRFS's Price Growth Rating (43) in the Pharmaceuticals Major industry is in the same range as GTX (53) in the null industry. This means that GRFS’s stock grew similarly to GTX’s over the last 12 months.
GTX's P/E Growth Rating (9) in the null industry is significantly better than the same rating for GRFS (96) in the Pharmaceuticals Major industry. This means that GTX’s stock grew significantly faster than GRFS’s over the last 12 months.
| GRFS | GTX | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 80% | 2 days ago 89% |
| Stochastic ODDS (%) | 2 days ago 68% | 2 days ago 73% |
| Momentum ODDS (%) | N/A | 2 days ago 74% |
| MACD ODDS (%) | 2 days ago 80% | 2 days ago 80% |
| TrendWeek ODDS (%) | 2 days ago 73% | 2 days ago 74% |
| TrendMonth ODDS (%) | 2 days ago 72% | 2 days ago 73% |
| Advances ODDS (%) | 10 days ago 72% | 10 days ago 68% |
| Declines ODDS (%) | 2 days ago 75% | 17 days ago 73% |
| BollingerBands ODDS (%) | 2 days ago 79% | 2 days ago 79% |
| Aroon ODDS (%) | 2 days ago 74% | 2 days ago 63% |
Advertisement
GRFS and
Correlation & Price change
A.I.dvisor indicates that over the last year, GRFS has been closely correlated with GIKLY. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if GRFS jumps, then GIKLY could also see price increases.
| Ticker / NAME | Correlation To GRFS | 1D Price Change % | ||
|---|---|---|---|---|
| GRFS | 100% | -1.92% | ||
| GIKLY - GRFS | 68% Closely correlated | N/A | ||
| GIFOF - GRFS | 37% Loosely correlated | N/A | ||
| PFE - GRFS | 28% Poorly correlated | -0.50% | ||
| BIIB - GRFS | 27% Poorly correlated | -0.02% | ||
| GILD - GRFS | 24% Poorly correlated | N/A | ||
More | ||||
GTX and
Correlation & Price change
A.I.dvisor indicates that over the last year, GTX has been loosely correlated with LKQ. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if GTX jumps, then LKQ could also see price increases.